ReviewCureus2024

Safety and Efficacy of Baricitinib, Upadacitinib, and Sarilumab Implementation in Moderately-to-Severely Active Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Current Evidence.

Giannis Meziridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.